5 months ago
CRVO
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 26%
#1287 out of 4980 analysts
Average Return
+14.19%
Win Rate
56%10 out of 18
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cervomed IncCRVO | +331.78% | $2.36 | $10.19 | 2025-03-11 - 2025-08-14 | Strong Buy |
Verona Pharma PLCVRNA | +132.90% | $45.20 | $105.27 | 2025-01-10 - 2025-08-14 | Strong Buy |
Verona Pharma PLCVRNA | +15.78% | $90.92 | $105.27 | 2025-06-18 - 2025-08-14 | Strong Buy |
Cervomed IncCRVO | +9.10% | $9.34 | $10.19 | 2025-03-18 - 2025-08-14 | Strong Buy |
Polypid LtdPYPD | +8.54% | $3.16 | $3.43 | 2025-06-05 - 2025-08-14 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
5 months ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +289.61% | Maintains | 2 days ago |
Cervomed IncCRVO | 4 | Strong Buy | $16.00 | +57.02% | Reiterates | 3 days ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $12.00 | +54.24% | Maintains | a month ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +10.19% | Reiterates | 2 months ago |
Polypid LtdPYPD | 2 | Strong Buy | $9.00 | +162.39% | Maintains | 2 months ago |
Cingulate IncCING | 2 | Strong Buy | $11.00 | +166.34% | Maintains | 3 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $7.00 | +1,402.15% | Initiates Coverage On | 7 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | +452.38% | Initiates Coverage On | 8 months ago |
Longeveron IncLGVN | 1 | Strong Buy | $10.00 | +1,224.50% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.